Stevens L M, Brown S R, Mueller T. "Method for the Synthesis of Daclatasvir Impurity 28" [P]. US Patent, US 11243281 B2, 2019-08-09.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 达拉他韦杂质28 in Pharmaceutical Formulations". Phytochemistry, 2018, 596, (11), 8019-8037.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达拉他韦杂质28 as an Impurity". Food Chem., 2025, 645, (1), 9912-9931.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Daclatasvir Impurity 28 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2018, 1663, (2), 1320-1347.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 达拉他韦杂质28 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2020, 463, 3454-3484.